Pacific Biosciences Of Stock Investor Sentiment
| PACB Stock | USD 1.26 0.01 0.80% |
About 53% of Pacific Biosciences' investors are presently thinking to get in. The analysis of overall sentiment of trading Pacific Biosciences of stock suggests that some investors are interested at this time. The current market sentiment, together with Pacific Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Pacific Biosciences stock news signals to limit their universe of possible portfolio assets.
Comfort Level 53
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Pacific Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Pacific Biosciences of.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Pacific Historical Sentiment
Although Pacific Biosciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Pacific, such as negative comments on social media and news outlets, may cause fear in the market and push Pacific Biosciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Pacific.
Pacific |
Pacific Biosciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Pacific Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Pacific Biosciences Historical Investor Sentiment
Investor biases related to Pacific Biosciences' public news can be used to forecast risks associated with an investment in Pacific. The trend in average sentiment can be used to explain how an investor holding Pacific can time the market purely based on public headlines and social activities around Pacific Biosciences of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pacific Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pacific Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Pacific Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Pacific Biosciences.
Far too much social signal, news, headlines, and media speculation about Pacific Biosciences that are available to investors today. That information is available publicly through Pacific media outlets and privately through word of mouth or via Pacific internal channels. However, regardless of the origin, that massive amount of Pacific data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pacific Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pacific Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pacific Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pacific Biosciences alpha.
Pacific Biosciences Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 25000 shares by Mohr Marshall of Pacific Biosciences at 4.45 subject to Rule 16b-3 | 12/27/2024 |
2 | PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference | 01/02/2025 |
3 | PacBio Names Global Institute for Food Security as Canadas First Revio Certified Service Provider | 01/23/2025 |
4 | Clinical Oncology Next-Generation Sequencing Market Research and Forecasts 2023-2024 2034 Use of Comprehensive Genomic Profiling, Regulatory Support, and Reimbu... | 02/05/2025 |
5 | Pacific Biosciences of California Inc Q4 2024 Earnings Call Highlights Navigating ... | 02/14/2025 |
6 | Disposition of 259909 shares by Henry Christian O of Pacific Biosciences at 1.878 subject to Rule 16b-3 | 02/18/2025 |
7 | PacBio to Participate in TD Cowens 45th Annual Health Care Conference | 02/19/2025 |
8 | Pacific Biosciences Uncertain Federal Research Funding Latest Blow For Already-Battered Stock - Seeking Alpha | 02/25/2025 |
9 | Disposition of 2973 shares by Farmer Michele of Pacific Biosciences at 1.407 subject to Rule 16b-3 | 03/03/2025 |
10 | 1 Healthcare Stock to Target This Week and 2 to Turn Down | 03/11/2025 |
11 | Pacific Biosciences of California Increases Yet Falls Behind Market What Investors Need to Know - Nasdaq | 03/14/2025 |
12 | Scientists Solve One of Genomics Biggest Challenges by Using HiFi Sequencing to Distinguish ... | 03/17/2025 |
13 | Pacific Biosciences of California Full Year 2024 Earnings EPS Beats Expectations | 03/19/2025 |
Complementary Tools for Pacific Stock analysis
When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |